Oppenheimer Reiterates Outperform Rating on UroGen Pharma (URGN), 'reiterate URGN as a top pick'

Go back to Oppenheimer Reiterates Outperform Rating on UroGen Pharma (URGN), 'reiterate URGN as a top pick'
(NASDAQ: URGN) Delayed: 47.85 -0.27 (0.56%)
Previous Close $48.12    52 Week High
Open $47.68    52 Week Low
Day High $47.95    P/E N/A 
Day Low $46.62    EPS
Volume 127,578